Connect Biopharma Holdings annual depreciation and amortization
2021
2022
2023
2024
2025
Connect Biopharma Holdings Depreciation & Amortization Growth & History (CNTB)
Connect Biopharma Holdings's depreciation and amortization was $704,000 for fiscal 2025.
View full Connect Biopharma Holdings company overviewConnect Biopharma Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $704,000 | $44,000 | +6.67% |
| 2024 | 2024-12-31 | $660,000 | −$60,000 | −8.33% |
| 2023 | 2023-12-31 | $720,000 | −$311,000 | −30.16% |
| 2022 | 2022-12-31 | $1.0M | $397,000 | +62.62% |
| 2021 | 2021-12-31 | $634,000 | — | — |
Connect Biopharma Holdings quarterly depreciation and amortization
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $161,000 | −$10,000 | −5.85% |
| Q1 2026 | 2026-03-31 | $164,000 | −$9,000 | −5.20% |
| Q4 2025 | 2025-12-31 | $181,000 | — | — |
| Q3 2025 | 2025-09-30 | $179,000 | $3,000 | +1.70% |
| Q2 2025 | 2025-06-30 | $171,000 | $9,000 | +5.56% |
| Q1 2025 | 2025-03-31 | $173,000 | $9,000 | +5.49% |
| Q3 2024 | 2024-09-30 | $176,000 | — | — |
| Q2 2024 | 2024-06-30 | $162,000 | — | — |
| Q1 2024 | 2024-03-31 | $164,000 | — | — |
Connect Biopharma Holdings depreciation and amortization trends
Between the periods ended 2021-12-31 and 2025-12-31, Connect Biopharma Holdings's depreciation and amortization increased from $634,000 to $704,000, a change of $70,000. The latest reported quarter, Q2 2026, shows $161,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Connect Biopharma Holdings source filings ↗